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Arrhythmogenic right ventricular dysplasia/cardiomyopathy
(ARVD/C) is a genetically determined cardiomyopathy
characterized by ﬁbrofatty replacement of predominantly
right ventricular (RV) myocardium.1 Morphologic changes
frequently occur at the inferior-subtricuspid and mid-RV
outﬂow tract, and may involve the anteroapical region in
severe cases (triangle of dysplasia).2 As disease progresses,
global RV dilation and RV dysfunction may occur. RV
structural changes may also lead to development of func-
tional tricuspid regurgitation (TR), often in the absence of
pressure overload from the pulmonary vasculature (eg,
pulmonary hypertension or left heart failure). Therefore,
TR in the context of ARVD/C may represent a unique
phenotype of patients with functional TR. Because RV
volume overload from signiﬁcant TR may in turn worsen
RV function, surgical correction of TR could have therapeu-
tic beneﬁt. Both signiﬁcant TR and RV dysfunction have
been independently associated with worse prognosis in
ARVD/C.3,4 In order to better understand the potential role
of surgery in these patients, we reviewed our ARVD/C
database to identify patients who underwent surgical
correction of TR.KEYWORDS Arrhythmogenic right ventricular dysplasia/cardiomyopathy;
Tricuspid regurgitation; Surgical repair; Surgical replacement; Right heart
failure
ABBREVIATIONS ARVD/C ¼ arrhythmogenic right ventricular dysplasia/
cardiomyopathy; ICD¼ implantable cardioverter-defibrillator; LV¼ left
ventricular; LVEF ¼ left ventricular ejection fraction; RA ¼ right atrial;
RV ¼ right ventricular; RVSP ¼ right ventricular systolic pressure; TEE¼
transesophageal echocardiography; TR ¼ tricuspid regurgitation; TTE ¼
transthoracic echocardiography; TV ¼ tricuspid valve; VT ¼ ventricular
tachycardia (Heart Rhythm Case Reports 2015;1:326–330)
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The Johns Hopkins ARVD Program maintains a research
registry of over 1000 ARVD/C patients, patients’ family
members, and those with borderline phenotypes. Patients are
followed at yearly intervals. We searched the program
registry for patients with a deﬁnite diagnosis of ARVD/C
according to the 2010 Task Force Criteria1 (n ¼ 321) who
underwent surgical treatment for TR and found 3 such
patients (Table 1). All underwent genetic testing for ARVD/
C, and at minimum were screened for desmoplakin, plako-
philin 2, plakoglobin, desmoglein 2, and desmocollin gene
mutations. One patient was found to have a pathogenic
mutation (case 3). All identiﬁed subjects (or their surrogate)
gave written informed consent to participate in the study,
which was approved by our Institutional Review Board.Case 1
Tricuspid valve replacement for severe tricuspid regurgita-
tion and stage D, NYHA class IV biventricular failure.
A 66-year-old male subject with previously established
ARVD/C and heart failure necessitating multiple hospital-
izations over the preceding 15 years presented with pro-
gressive dyspnea, worsening ﬂuid retention, abdominal
distension, and congestive hepatopathy. He was able to walk
only with the help of a cane. He had NYHA class IV
symptoms but denied signiﬁcant left-sided heart failure
symptoms including orthopnea or paroxysmal nocturnal
dyspnea. He had been turned down for heart transplantation
at 3 different centers owing to a combination of suspected
liver disease and amiodarone-induced lung disease. In
addition to heart failure, his ARVD/C course was remarkable
for signiﬁcant atrial and ventricular arrhythmias, requiring
multiple ablation attempts, antiarrhythmic therapy, and
implantation of a cardiac resynchronization therapy deﬁb-
rillator device.
Transthoracic echocardiography (TTE) showed severe
right atrial (RA) and RV dilation (RV internal diameter 8.1
cm), with severe global hypokinesis of the right ventricle.
There was septal ﬂattening consistent with RV volumepen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.05.001
KEY TEACHING POINTS
 Structural changes that occur in arrhythmogenic
right ventricular dysplasia/cardiomyopathy (ARVD/
C) may predispose to tricuspid regurgitation
developing in the absence of signiﬁcant left heart
disease or pulmonary hypertension.
 There is little evidence to guide therapy for ARVD/C
patients with right ventricular structural changes
and heart failure.
 The role for surgical correction of tricuspid
regurgitation in these patients is intriguing but
requires further study.
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[RVSP] 31 mm Hg). Left ventricular ejection fraction
(LVEF) was 30%–40%. Preoperative right heart catheter-
ization showed an RA pressure of 15 mm Hg, normal
pulmonary vascular resistance (1.8 Wood units), and a low
right ventricular stroke work index of 1.8 g * m/m2. Left-
sided ﬁlling pressures were borderline (pulmonary capillary
wedge pressure of 15 mm Hg).
Given his lack of other clinical options and signiﬁcant
symptoms, he was referred for high-risk tricuspid valve
(TV) repair/replacement. Intraoperative transesophageal
echocardiography (TEE) showed that the TV annulus was
severely dilated (5.2 cm), with tethering of the anterior TV
leaﬂet. A downsizing annuloplasty was performed and a 30
mm Edwards MC3 ring was initially seated. Because
tethering of the anterior TV leaﬂet was still apparent, the
annuloplasty ring was removed and the annulus downsized
further with sutures, before a 31 mm Medtronic Mosaic
valve replacement was successfully seated. There was no
annular dilation postoperatively and TR was only trace.
Bypass time was 153 minutes and the case was performed
without cardiac arrest.
The initial postoperative course was complicated by
signiﬁcant volume overload and thrombocytopenia, but
after signiﬁcant diuresis the patient was discharged on
postoperative day 18. TTE at 9 months showed less RV
dilation (RV internal diameter 5.3 cm) and stable left
ventricular (LV) function (LVEF 39%). The patient has
been followed for 18 months and has experienced sympto-
matic improvement with return to NYHA class II/III
symptoms, although he still requires signiﬁcant diuretics.
He ambulates without a cane and has returned to perform-
ing many routine activities of daily living. He has not
experienced any sustained ventricular arrhythmias or
implantable cardioverter-deﬁbrillator (ICD) discharges
since surgery.Case 2
Tricuspid valve repair for severe tricuspid regurgitation and
stage C, NYHA class III, isolated right ventricular failureA 68-year-old male subject with a 12-year history of right
heart failure presented with a history of progressive dyspnea
on exertion, fatigue, and worsening lower extremity edema
consistent with NYHA class III limitations. His medical
history was also remarkable for chronic atrial ﬁbrillation and
exercise-induced ventricular tachycardia (VT). TTE showed
severe RA and isolated RV dilation with moderate to severe
RV global systolic hypokinesis. Severe TR was present with
a normal RVSP (27 mm Hg). There was paradoxical septal
motion consistent with volume overload. Additionally, mild
mitral regurgitation associated with mitral valve prolapse
was present, which had been noted since the initial heart
failure diagnosis.
The patient underwent TV Duran ring annuloplasty and
RA reduction on cardiopulmonary bypass (23 minutes) but
without cardiac arrest. Intraoperative TEE after repair
showed no TR with reported improvement in RV size and
function. He was discharged on low-dose furosemide, which
was stopped at 6 months of follow-up. By the second year of
follow-up, however, moderate TR was again present along
with moderate mitral regurgitation. In the years following
valve repair, he suffered signiﬁcant VT, requiring 2 endo-
cardial ablations, antiarrhythmic therapy, and implantation
of an ICD. He was diagnosed with ARVD/C 2 years after his
TV surgery. His ECG is shown in Figure 1 (epsilon waves
are noted). The patient died of accidental causes 5 years
postoperatively.Case 3
Tricuspid valve repair for moderate tricuspid regurgitation
and isolated stage C, NYHA class II, isolated right ven-
tricular heart failure
A 17-year-old girl presented after identiﬁcation of an
incidental holosystolic cardiac murmur on routine phys-
ical examination. Echocardiography at that time showed
mild to moderate TR (normal RVSP 28 mm Hg) and RV
dilation (RV internal diameter 3.9 cm). Over the following
2 years, she developed mild symptoms during signiﬁcant
exertion (NYHA class II), not requiring speciﬁc therapy.
She also had an episode of VT (diagnosed as RV outﬂow
tract VT) for which she had 1 endocardial ablation; no ICD
was implanted. A cardiac magnetic resonance image
showed moderate RV dilation (RV end-diastolic volume
131.25 ml/m2) with moderate global systolic hypokinesis
(RV ejection fraction 30%), moderate TR (regurgitant
fraction 40%), and normal LV function. As compared to
previous studies, this study showed progression of TR, RV
dilation, and deterioration in function; therefore surgical
correction of TR was pursued for what was felt to be
primary TR.
TV valvuloplasty was performed with closure of an
accessory commissure of the anterior leaﬂet. Moderate TR
persisted intraoperatively and therefore a modiﬁed De Vega
annuloplasty (Reed) was performed. At this point, an intra-
operative TEE still demonstrated moderate TR and chordal
lengthening of the anterior TV leaﬂet was accomplished. The
Table 1 Perioperative patient characteristics and echocardiographic data
Case 1 Case 2 Case 3
Sex/race Male/white Male/white Female/white
Age/presentation 50/syncope 56/syncope 17/incidental murmur
2010 Task Force Criteria
Structural alterations Major Major Major
Tissue characterization N/A Major N/A
Repolarization abnormalities Minor Major Major
Depolarization abnormalities None Major Minor
Arrhythmias Major Minor Minor
Family history/genetics None None Major/PKP2: heterozygous,
c.224-3, C4G
Diagnosis Deﬁnite Deﬁnite Deﬁnite
Heart failure / procedure
*Preoperative **Postoperative *Preoperative **Postoperative *Pre operative **Postoperative
Age at procedure 66 69 19
Symptom class NYHA IV NYHA II/III NYHA III NYHA I NYHA II NYHA II/III
Diuretics Yes Yes Yes No No Yes
Procedure Bioprosthetic replacement
after attempted repair
Ring annuloplasty Suture annuloplasty
and valvuloplasty
Echocardiographic features
RV dilation Severe Moderate Severe Moderate–severe Moderate Severe
RV function Severe global HK Moderate–severe global HK Severe global HK Severe global HK Preserved Severe global HK
TR Severe Trace Severe Moderate Moderate Moderate
LV function Reduced, EF 30-40% Reduced, EF 35-40% Normal, EF ¼ 60% Normal, EF ¼ 60% Normal, EF ¼ 79% Normal, EF ¼ 69%
NYHA¼ New York Heart Association; RV¼ right ventricular; LV¼ left ventricular; TR¼ tricuspid regurgitation; HK¼ hypokinesis; EF¼ ejection fraction; NYHA¼ New York Heart Association; RV¼ right ventricular;
LV ¼ left ventricular; TR ¼ tricuspid regurgitation; HK ¼ hypokinesis; EF ¼ ejection fraction.
*Most recent data or study available before surgery.













Figure 1 ECG (case 2). Epsilon waves (arrows) are noted in lead V2.
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distinct jets, yet TR was noted as moderate by the time of
discharge. The procedure was conducted on cardiopulmonary
bypass and the heart was arrested with aortic cross-clamping
(times unknown).
The patient’s clinical symptoms (mild dyspnea on exer-
tion and intermittent peripheral edema requiring as-needed
diuretics) remained stable over the next 4 years, as did the
severity of TR and RV dilation/dysfunction. By the ﬁfth year
of follow-up, there was progression of TR to severe and more
RV dilation/dysfunction (RV internal diameter 3.9 cm and
tricuspid annular plane systolic exertion 0.9 cm) with septal
ﬂattening consistent with RV volume overload (RVSP 30
mm Hg). This was associated with dyspnea occurring during
moderate exertion with intermittent lower extremity edema
requiring as-needed furosemide. A second endocardial
ablation was also performed owing to recurrence of VT
along with implantation of an ICD.
This patient was diagnosed with ARVD/C a year and a
half after her initial TV operation. She was found to have 2
heterozygous mutations: (1) a splice site mutation involving
a C4G base substitution at position c.224 of the plakophilin
2 gene (this mutation has previously been described in 1
patient with ARVD/C outside our registry)5; and (2) a
missense mutation in the troponin T type 2 gene, which
has been associated with hypertrophic and dilated
cardiomyopathies.Discussion
Main ﬁndings
We present 3 patients with signiﬁcant TR and symptomatic
RV dysfunction who underwent surgical intervention. Two
patients (cases 1 and 2) showed symptomatic improvement
following surgical correction of TR. Both of these patients
were older men with prolonged, progressive heart failure
courses and had developed severe TR with evidence of RV
volume overload at the time of surgery, in the absence ofsigniﬁcant pulmonary hypertension. In case 1, the patient
underwent valve replacement after initial attempts at repair
were inadequate. There was no signiﬁcant TR at 18 months
follow-up. In case 2, the patient underwent valve repair and
initially showed signiﬁcant radiologic and clinical improve-
ment. Moderate TR was evident by 1 year of follow-up,
although the patient remained clinically improved. The
patient in case 3 underwent valve repair to correct what
was considered primary TR. However, moderate TR was still
present postoperatively, which progressed to severe TR by
the end of follow-up. Only in case 1 had the patient been
diagnosed with ARVD/C at the time of TV surgery.
Surgical correction of tricuspid regurgitation in arrhyth-
mogenic right ventricular dysplasia/cardiomyopathy
In the general population, moderate to severe TR is
associated with worse survival regardless of LVEF or
pulmonary artery pressure.5 RV dysfunction secondary to
TR is also an independent determinant of mortality.6
Although less well deﬁned, both factors also seem to predict
prognosis in ARVD/C.3,4 As the majority of functional TR is
considered to be secondary to left-sided heart disease,
surgical correction of functional TR is currently indicated
only at the time of left-sided valve surgery.7 Isolated TV
surgery, on the other hand, is indicated for patients with
severe primary TR who either are symptomatic or have
evidence of RV dysfunction.7 There is some evidence that
early surgical intervention (RV end-systolic area o20 cm2)
may improve outcomes and functional capacity in these
patients.8 In patients with severe functional TR due to
intrinsic RV changes, as is the case with ARVD/C, it is
feasible that correction of TR could delay development of
overt RV dysfunction, potentially due to reversal of chronic
RV volume overload. However, one must also consider the
potential worsening of RV function during cardiac surgery,
secondary to septal damage or loss of pericardial integrity.9
To the best of our knowledge, this is the ﬁrst study to
describe the course of multiple patients with deﬁnite ARVD/
C who undergo surgical correction of TR. There are 5
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the literature.10–14 Jiang et al10 reported a case of a patient
with long-standing heart failure who underwent TV repair in
the setting of progressive and refractory symptoms. This
patient experienced an early postoperative death due to low
cardiac output. Similar to the patient in case 1, this patient
had a depressed LVEF, although no preoperative hemody-
namic data were available to help quantify the severity of LV
failure or presence of pulmonary hypertension.10 Therefore,
it is possible that this patient may have had signiﬁcant
pressure overload contribution to RV failure and TR, and
thus, TV repair could have increased RV load and worsened
RV failure. In the case described by Gwizdala et al,11 a
patient underwent TV repair for what was thought to be
primary TR, similar to case 3. After an initial improvement
during the ﬁrst few years after surgery, the patient developed
progressive biventricular heart failure and eventually was
referred for cardiac transplantation.11 The third report
describes a patient with severe TR and biventricular failure
that underwent valve replacement along with epicardial
deﬁbrillator lead implantation.12 Improvement was noted in
the immediate postoperative course; however, the patient
was only followed to discharge.12 Finally, 2 authors report
successful outcomes at long-term follow-up after TV repair.
Both patients had severe TR, severe RV dilation, and
biventricular heart failure, but also signiﬁcant mitral regur-
gitation, and underwent simultaneous mitral valve
procedures.13,14
This issue of whether to repair or replace the tricuspid
valve merits further discussion. In our series, the patient in
case 1 underwent TV replacement (after attempted repair)
and has had no TR identiﬁed during follow-up with
signiﬁcant improvement in symptoms. By contrast, the
patients in cases 2 and 3, who both underwent repair
procedures, saw return of TR during follow-up. In a recent
study by Yiu et al15 of patients undergoing TV repair,
signiﬁcant RV mid-cavity diameter dilation and TV tethering
area were the 2 strongest predictors of postoperative adverse
events. It was felt that inadequate surgical correction of TR
and RV geometry were contributing factors to the adverse
events. It is conceivable that patients with ARVD/C, who can
have severe and progressive RV and TV structural changes,
may fare better with replacement than repair. Additionally,
many patients with ARVD/C will have ICD leads crossing
the TV, which could theoretically damage the valve and
contribute to worsening TR. In our series, only the patient in
case 1 had an ICD before valve surgery was performed and
this was left in place after valve replacement. Whether or not
patients undergoing TV surgery should have lead revisions
and/or epicardial lead placement at the time of surgery is
unknown but may be worth considering.Conclusion
In summary, our series suggests that surgical correction of
functional TR in the context of signiﬁcant RV dilation and
RV volume overload could potentially improve heart failure
symptoms in certain patients with ARVD/C. Further study of
this treatment strategy, as well as deﬁning the role of TV
repair vs replacement in this situation, is warranted.
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